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Abstract 
Introduction: The ratio of birthweight to placental weight (BW:PW) is often used as a measure 
of placental efficiency in humans and animals. However, ratios have properties that are known to 
lead to spurious results. An alternative approach is the use of residuals from regression, which 
reflect whether birthweight is higher or lower than expected for a given placental weight, given 
the population pattern. We hypothesized that biologically meaningful measures of placental 
efficiency would differ between placentas with and without pathology, and between adverse and 
normal perinatal and postnatal outcomes.   
Methods: We examined associations between measures of placental efficiency (BW:PW ratio or 
residuals) and placental pathology, Apgar scores and infant death using National Collaborative 
Perinatal Project data (4645 preterm births and 28497 term births). 
Results: BW:PW ratios and residuals were significantly lower in placentas showing pathologies 
including signs of large infarcts or hemorrhage, although many of these differences were small. 
Low BW:PW ratios and residuals were also associated with low Apgar scores and increased risk 
of postnatal death. Whereas residuals were lower in term placentas that appeared immature by 
microscopic examination, the opposite was true for BW:PW ratios. 
Conclusion: The BW:PW ratio produced an artefact whereby histologically less mature placentas 
at term appeared to be more “efficient” than mature placentas, illustrating a known problem with 
the use of ratios. For other traits, residuals generally showed differences between placentas with 
and without pathology that were as great as those seen with BW:PW ratios, and often showed 
stronger associations with adverse outcomes. 
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1. Introduction
Placental dysfunction is a major cause of fetal growth restriction and stillbirth [1], and places the 
newborn at increased risk of postnatal complications and health problems throughout life [2]. 
Assessments of placental function and the effects of gestational insults frequently use the ratio of 
birthweight to placental weight (BW:PW) as a proxy measure of placental efficiency [3]. 
BW:PW ratio has been suggested to reflect placental exchange surface area, rates of nutrient 
transport and blood flow [2], potentially reflecting adjustments in placental development and/or 
function in order to meet fetal demand [3]. While a high number of grams of fetus per gram of 
placenta may be considered efficient in some sense, the phrase “efficiency” implies aspects of 
placental function, e.g., rates of nutrient transport per gram of placenta. While the BW:PW ratio 
often shows the expected relationship with measures of nutrient transport, surface area and 
vasculature [3–5], this is not always the case in humans [6] and other species [3]. 
Gross measures such as birthweight and placental weight provide an approximate 
assessment of placental development and function, but it is not clear that a simple ratio is the best 
way to combine these two variables, as there are inherent properties of ratios that can lead to 
spurious results. In particular, if a regression of Y on X is not linear and/or if it does not pass 
through the origin, the ratio of Y:X will change along the regression line [7–10]. A plot of 
birthweight against placental weight, with shading indicating the BW:PW ratio, is shown in Fig. 
1 (data described below). Babies on the regression line (i.e., babies with the expected weight for 
their placental size) have lower ratios as placental weight increases. Furthermore, a small baby 
with a small placenta below the regression line may have a higher BW:PW ratio than a big baby 
with a big placenta that is above the regression line, i.e., some babies that are smaller than 
expected for their placenta size have higher placental “efficiency” than other babies that are 
bigger than expected for their placenta size. This is unlikely to be the case and, rather, may be an 
artefact of the use of BW:PW as a proxy of efficiency. In some cases, smaller fetuses with small 
placentas will indeed demonstrate increased rates of nutrient transfer measured per gram of 
placenta [3–6]. However, the BW:PW ratio does not provide evidence of this. The change in 
BW:PW ratio with placental size occurs because the intercept (i.e., the predicted birthweight 
when placental weight is zero) is not zero. It therefore reflects a known artefact of ratios [7–9], 
and not interesting biology. A biological interpretation of the non-zero intercept (i.e., why the 
predicted birthweight is positive when placental weight is zero) would be difficult and 
controversial at best. Such plots cannot be interpreted in terms of developmental trajectories, i.e., 
a plot of term or near-term births does not reflect the relationship between fetal and placental 
weight throughout gestation. 
The issue of the linearity of the relationship between birthweight and placental weight 
has been considered by Salafia et al. [11], who suggested that the ratio should be calculated as 
BW0.75:PW on theoretical grounds. This approach could potentially address the issue of 
nonlinearity of the relationship between birthweight and placental weight, but would not address 
the problem of a non-zero intercept. Furthermore, this approach assumes a scaling exponent to be 
a specific value based on theory, which was valid for the dataset analysed, but which might not 
hold true in other datasets (e.g., using a broader/ narrower range of gestational ages). 
An alternative approach to combining birthweight and placental weight to assess 
placental function is the use of residuals from a linear regression [7–9]. A residual is the 
difference between the actual value of the dependent variable (in this case, birthweight), and its 
predicted value based on the regression line. Residuals thus indicate whether birthweight is 
higher or lower than expected for a given placental weight, given the population pattern. The 
goal of this study is to compare the use of the BW:PW ratio, the BW0.75:PW ratio, and residuals 
as measures of “placental efficiency”. We hypothesize that biologically meaningful measures of 
placental efficiency will differ between placentas with and without pathology, and between 
adverse and normal perinatal and postnatal outcomes, and test predictions from this hypothesis 
using data from the National Collaborative Perinatal Project. Given the previous work on the 
allometric scaling of placental weight with birthweight [11], we also examine whether the 
scaling exponent is sensitive to the range of gestational ages included. 
2. Methods
The National Collaborative Perinatal Project (NCPP) has been described elsewhere, and its data 
are publicly available (https://catalog.archives.gov/id/606622). We used only singleton, live 
births where offspring sex was assigned male or female; stillbirths were excluded, but cases with 
neonatal deaths were included. Where a woman had more than one pregnancy included in the 
study, we included only her first study pregnancy, resulting in 43673 eligible births. We 
performed analyses separately for preterm (24 - 36 weeks, inclusive, based on the limit of 
viability [12]; N = 5967) and term (37 – 43 weeks, inclusive; N = 34907) births given that the 
BW:PW ratio would be expected to change with gestational age; in this dataset gestational age 
was calculated based on the last menstrual period to the nearest week. Cases were not excluded 
on the basis of maternal health conditions or congenital abnormalities.  
Some clear errors in the data were observed (e.g., a placenta weight of 28 g at term), and 
so to objectively exclude biologically implausible values, we excluded the top and bottom 0.5% 
of raw birthweights and placental weights (determined separately for preterm and term) [11]. 
Placental weights were obtained from fresh placentas trimmed of cord and membranes. At term, 
the 10th and 90th percentiles for placental weight were 330 g and 560 g, while those for 
birthweight were 2637 g and 3827 g. Corrected values of birthweight and placental weight were 
calculated using the residuals from a general linear model with effects of maternal race, offspring 
sex and gestational age. This resulted in 4645 preterm and 28497 term pregnancies with 
corrected values of both birthweight and placental weight. These corrected values were used to 
calculate the BW:PW ratio, as well as the ratio of BW0.75:PW [11]. As an alternative measure of 
placental efficiency, we also obtained the residuals of the linear regression of corrected 
birthweight on corrected placental weight using the RESIDUAL statement of proc GLM (SAS, 
Version 9.4). Because residuals are highly correlated with birthweight, we also used corrected 
birthweight itself as a measure of placental efficiency, resulting in four measures: BW:PW, 
BW0.75:PW, birthweight and residuals.  Each of these measures was standardized to have a mean 
of 0 and standard deviation of 1 to facilitate comparison.  
We tested whether each of the four measures of placental efficiency differed between 
placentas that would be expected to have a larger functional surface area for exchange (i.e., those 
with no pathology) and those expected to be less efficient (i.e., those with signs of pathology). 
We examined aspects of placental pathology previously found to be associated with childhood 
disease in this cohort [13]: Type of cord insertion, the size of infarcts observed upon gross 
examination of the placenta and, from microscopic placental examination, the presence of 
thrombosis or necrosis in the fetal surface vasculature, stromal fibrosis or pathological edema in 
the terminal villi, and the presence of intervillous thrombi and/or adjacent villous infarction. In 
addition, we also examined placental pathologies expected to reduce the functional exchange 
surface: the presence of hemorrhage and/ or decidual necrosis (both observed upon gross 
examination) and the apparent maturity of the placenta, assessed upon microscopic examination. 
Criteria for assessing  maturity included the presence of fibrin under the chorionic plate, the 
presence of cysts on the cut surfaces, the presence of syncytial knots, the lack of the Langhans 
layer, uniformity of villous size, and the degree of crowding of fetal capillaries within villi [14]. 
Pathologies associated with inflammation were not analyzed given that these might be associated 
with recent acute inflammation and/or infection. 
The difference between placentas without and with pathology is expected to be positive 
(i.e., higher measures of placental efficiency in placentas with no pathology) and in standard 
deviation units (e.g., a difference of 1 indicates that pathological and non-pathological placentas 
differ in placental efficiency by 1 standard deviation). The difference in measures of placental 
efficiency between placentas with and without pathology was calculated using the ESTIMATE 
statement of proc GLM (SAS, Version 9.4). We also used logistic regression (proc LOGISTIC, 
SAS, Version 9.4) to test whether each of the four measures was associated with neonatal and 
infant outcomes, i.e., the risk of a poor Apgar score at 1 or 5 minutes, and infant death. 
In addition, we assessed whether the allometric scaling exponent was sensitive to the 
range of gestational ages included in its calculation. The allometric scaling exponent was 
calculated as the slope of the regression of the natural logarithm of placental weight on the 
natural logarithm of birthweight, with the widest range of ages included being 34 – 42 weeks, 
inclusive (as in [11]). For these analyses, we excluded women with any repeat pregnancies in the 
study, and used raw values (unstandardized and uncorrected for gestational age, sex and race) to 
be consistent with the previous study [11].  
3. Results
3.1. Measures of placental efficiency in term births 
The distributions of the BW:PW ratio and the BW0.75:PW ratio were slightly positively skewed, 
while the distributions of birthweight and residuals were closer to normal (Supplementary Figure 
1). Among term births, the BW:PW ratio and the residuals of birthweight on placenta weight 
were significantly higher in placentas without certain pathologies (without infarcts, hemorrhage, 
intervillous thrombi and/or adjacent villous infarction), as predicted (Table 1). While significant, 
the differences between placentas with and without pathology were generally very small (< 0.3 
standard deviation units). For the type of cord insertion, the residuals were significantly higher in 
placentas with non-membranous cord insertion, whereas there was no difference in the BW:PW 
ratio (Table 1).  While we excluded births at less than 37 weeks from these analyses, the 
apparent maturity of some placentas was assessed by microscopic examination to be less than 37 
weeks. Placentas assessed to be more mature had significantly higher residuals, as expected, but 
had significantly lower BW:PW ratios, i.e., placental efficiency, measured using the BW:PW 
ratio, was lower in placentas that morphologically appeared more mature. To investigate the 
discrepancy between residuals and BW:PW ratios further, we assessed where mature and 
immature placentas fell on the plot of birthweight against placental weight (Fig. 2). Not only did 
those classed as immature placentas result in lower birthweights (Table 1), but placental weight 
was also significantly lower (P < 0.0001, Fig. 2), such that births with immature placentas tended 
to be towards the lower end of the plot (resulting in higher ratios), but slightly below the 
regression line (resulting in lower residuals).  
Higher BW:PW ratios and residuals were associated with increased odds of good Apgar 
scores at 1 and 5 minutes, as expected, although there was no association with Apgar scores at 10 
minutes (Table 2). Similarly, higher BW:PW ratios and residuals were associated with increased 
odds of surviving to 120 days of age, although the odds ratio was substantially higher for 
residuals than for BW:PW ratios (Table 2). Larger residuals were associated with increased odds 
of surviving from 121-240 days, whereas there was no association with the BW:PW ratio (Table 
2). There was no association between the odds of surviving from 241-365 days with any measure 
of placental efficiency (Table 2), although only 22 infants died in this interval, and so power to 
detect association was lower. 
3.2. Measures of placental efficiency in preterm births 
As at term, the distributions of birthweight and residuals were slightly closer to normal than were 
those of the BW:PW ratio and the BW0.75:PW ratio (Supplementary Figure 2). As described 
above for term births, among preterm births, BW:PW ratios and residuals were significantly 
higher in placentas without certain pathologies (Table 3), although the pathologies showing 
significant differences were not always consistent between term and preterm births. For example, 
differences in BW:PW ratio between more mature and less mature placentas differed between 
term and preterm births. Although this analysis included only births at less than 37 weeks, the 
apparent maturity of some placentas was assessed by microscopic examination to be 37 weeks or 
greater, potentially reflecting accelerated maturation. Placentas assessed to be more mature had 
significantly higher residuals and BW:PW ratios, as expected. To investigate this discrepancy in 
results between term and preterm births, we examined plots of birthweight against placental 
weight (Supplementary Figure 3). The intercept was substantially lower for preterm births and, 
as a result, there was better concordance between residuals and BW:PW ratios in preterm than 
term births (i.e., higher BW:PW ratios above the regression line, lower BW:PW ratios below the 
regression line). This would explain why residuals and BW:PW ratios yielded similar results for 
preterm births but not term births.  
Among infants born preterm, larger BW:PW ratios and residuals were associated with 
increased odds of good Apgar scores at 1, 5 and 10 minutes (Table 4). Similarly, larger BW:PW 
ratios and residuals were associated with increased odds of surviving to 120 days of age (Table 
4). There was no association between measures of placental efficiency and the odds of surviving 
from 121-240 days (Table 4), although only 22 infants died in this interval, and so power to 
detect association was lower.  
Where significant differences in placental efficiency were observed between placentas 
with and without pathology, or between adverse and normal outcomes, the magnitudes of the 
differences and odds ratios were generally larger for preterm births than for term births. 
3.3. Scaling of placental weight with birthweight over different ranges of gestational age  
The allometric scaling exponent, calculated as the slope of the regression of the natural logarithm 
of placental weight on the natural logarithm of birthweight, increased substantially as the range 
of gestational ages included narrowed around 40 weeks (Fig. 3). When wider ranges of 
gestational ages were included, the slope of placental weight on birthweight was less steep 
because low birthweights were associated with heavier placentas than when the range narrowed 
around 40 weeks (Fig. 3).   
4. Discussion
Numerous studies use the size of a fetus or newborn relative to the size of its placenta as a 
measure of placental efficiency. However, expressing this metric as BW:PW is subject to 
undesirable properties of ratios that have been described in other fields [7–9]. We compared the 
standard BW:PW ratio and a modified ratio [11] to an alternative approach using the residuals of 
the regression of birthweight on placental weight. As expected, ratios and residuals were often 
reduced in placentas showing signs of pathology, although many of these effects were small. 
Pathology associated with ratios and residuals included infarction, hemorrhage and villous 
dysmaturity (or delayed villous maturation [15]), which are all frequently associated with 
stillbirth [1]. Ratios and residuals were also lower in newborns with lower Apgar scores and 
reduced prospects of postnatal survival. Previously, fetal death has been found to be associated 
with very high and very low BW:PW ratio preterm, and very high BW:PW ratio at term [16] 
whereas a recent study found that low BW:PW ratio at term was associated with neonatal 
morbidity (defined in terms of low Apgar score, metabolic acidosis and/or admission to the 
neonatal unit) [17]. In the present study, residuals almost always showed differences at least as 
great as the BW:PW ratio in terms of the magnitude of difference between placentas with and 
without pathology, or between adverse and normal outcomes. For some traits, birthweight alone 
showed greater differences than any of the measures incorporating placental weight.  
In the case of the apparent histological maturity of the placenta, in term placentas the 
BW:PW ratio produced a counterintuitive result: placental efficiency, measured using the 
BW:PW ratio, was higher in placentas that morphologically appeared immature. Signs of 
placental maturity include a lack of Langhans layer (i.e., layer of cytotrophoblast under the 
syncytiotrophoblast) and crowding of fetal capillaries within villi, such that they are right next to 
the villous surface [14]. These factors would reduce the distance between fetal and maternal 
blood, and so mature placentas would be expected to be more efficient. Indeed, increased 
trophoblast thickness is associated with fetal growth restriction [18,19]. Accelerated placental 
maturation is potentially a compensatory response to increase the surface area for exchange in 
pregnancies complicated by placental dysfunction [20,21], although responses at the molecular 
level are also involved [22,23]. The observation that the BW:PW ratio was increased in 
histologically immature term placentas illustrates a known problem with the use of ratios: if the 
regression of Y on X does not pass through the origin, the Y:X ratio will change for points along 
the regression line as X increases. In this case, immature placentas were lighter and so had higher 
BW:PW ratios, even though these births tended to fall below the regression line and so had lower 
residuals. The increased “efficiency” of immature placentas therefore reflects a mathematical 
artefact of ratios, and not biological efficiency. This misleading result was not observed among 
preterm births because of a much lower intercept which reduced the artefact of ratios and led to 
better concordance between BW:PW ratios and residuals. The artefact of small placentas having 
large BW:PW ratios may also explain why associations with postnatal death were weaker for 
BW:PW ratios than for residuals. 
It has been proposed that the ratio should be calculated as BW0.75:PW on theoretical 
grounds related to allometric scaling. However, in the present study the BW0.75:PW ratio often 
showed smaller differences between placentas with and without pathology, or between good and 
bad outcomes, than the BW:PW ratio. Furthermore, this approach assumes a specific allometric 
scaling exponent. However, we found that this scaling exponent is highly sensitive to the range 
of gestational ages included in its calculation. When including different ranges of gestational 
age, the slope of the relationship of placental weight on birthweight is less steep when a wider 
range of gestational ages is included. This is to be expected: when earlier gestational ages are 
included, there are more placentas that are relatively large for their babies (because their babies 
still had some growing to do), which raises the regression line on the left of the plot, leading to a 
less steep slope. Thus, when including only births within a narrow range of gestational age (40 
weeks) the slope reflects an allometric relationship (i.e., variation in size at a specific 
developmental stage). In contrast, when a wider range of gestational ages is included, the slope is 
influenced by the allometric relationship as well as ontogenic changes (i.e., changes with 
development) and potentially characteristics associated with premature birth.  
We recommend that the BW:PW ratio not be used as a measure of placental efficiency, 
and propose the use of the residuals of a regression of birthweight on placental weight as a 
simple alternative. The use of residuals is closely related to analysis of covariance (ANCOVA) 
[7–10] and, depending on the research question, ANCOVA or other modeling approaches are 
also appropriate. For example, rather than testing whether residuals differed between births from 
complicated pregnancies and controls, one can test whether birthweight differed between 
complications and controls, with placental weight as a covariate. Additional covariates and 
cofactors (e.g., gestational age, offspring sex, etc.) can be included easily. Alternatively, logistic 
regression can be used to model the risk of specific outcomes, e.g., the association between 
adverse perinatal outcomes and placental weight, adjusting for birthweight [24]. Whereas the 
BW:PW ratio can be calculated for an individual birth in isolation, the use of residuals requires a 
sample of births. However, meaningful interpretation of a BW:PW ratio requires a relevant 
reference population. Furthermore, with a reference population in hand, the regression equation 
can be used to calculate the predicted birthweight for a given placental weight and, therefore, the 
residual for an individual birth. 
Ratios are known to have undesirable properties [7–10]. In the present study, use of the 
BW:PW ratio produced an artefact whereby histologically less mature placentas at term appeared 
to be more “efficient” than mature placentas. Artefacts introduced by the use of ratios may also 
explain unexpected results such as increases in placental efficiency when birthweight and 
placental weight are both reduced by glucocorticoid treatment [3]. The increased BW:PW ratio 
of small placentas is a mathematical feature of ratios resulting from a non-zero intercept (i.e., the 
predicted birthweight when placental weight is zero). Small placentas may in fact be more 
efficient than large placentas, but such a conclusion requires independent assessment of 
“efficiency” (e.g., measurement of nutrient transport per gram placental tissue) [3–6], and cannot 
rely on the BW:PW ratio. To study placental efficiency independent of size, the undesirable 
properties of ratios can be avoided by using residuals. In the present study, residuals showed 
differences between placentas with and without pathology that were as great as those seen with 
BW:PW ratios, and often showed stronger associations with adverse outcomes.  
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Table 1. Associations between measures of placental efficiency and placental morphology/ pathology in term births (37 – 43 weeks). 
Values are in standard deviation units and indicate the difference (± standard error) between pregnancies where efficiency is expected 
to be greater (no pathology) and where efficiency is expected to be reduced, i.e., the difference is expected to be positive for all traits. 
Bold indicates significance at α = 0.05. 
Trait Sample size Difference between no pathology and pathology 
No 
pathology 
Pathology BW:PW BW0.75:PW Birth 
weight 
Residual 
Placental examination – Gross 
Type of cord insertion 
     Not membranous vs. marginal or membranous 
27180 1168 -0.02 ±
0.03
-0.07 ±
0.03
0.20 ± 
0.03 
0.15 ± 
0.03 
Cut surface infarct size 
     Not applicable or all infarcts less than 3 cm vs. at 
least one infarct measures 3 or more cm 
27425 934 0.14 ±
0.03
0.10 ± 0.03 0.21 ± 
0.03 
0.24 ± 
0.03 
Hemorrhage 
     Absent vs. present 
27389 921 0.12 ± 
0.03 
0.10 ± 0.03 0.08 ± 
0.03 
0.11 ± 
0.03 
Decidual necrosis 
     Not seen grossly or present, not massive vs. present, 
massive 
27194 1163 0.03 ± 
0.03 
0.02 ± 0.03 0.05 ± 
0.03 
0.05 ± 
0.03 
Placental examination - Microscopic 
Fetal surface vascular changes 
     None vs. thrombosis and/or necrosis 
27799 296 0.06 ± 
0.06 
0.06 ± 0.06 -0.00 ±
0.06
0.04 ± 
0.06 
Terminal villi- stromal fibrosis 
     Not seen vs. present 
27155 1056 -0.01 ±
0.03
-0.03 ±
0.03
0.05 ±
0.03
0.03 ± 
0.03 
Terminal villi- pathological edema 
     Not seen vs. present 
27194 1019 0.05 ±
0.03
0.05 ± 0.03 -0.03 ±
0.03
0.00 ± 
0.03 
Intervillous thrombi and adjacent villous infarction 
     Not seen vs. present 
25714 2482 0.16 ±
0.02
0.17 ± 0.02 -0.07 ±
0.02
0.05 ± 
0.02 
Apparent maturity of the placenta 
     37 weeks or over vs. 36 weeks or less 
26301 1897 -0.24 ±
0.02
-0.32 ±
0.02
0.36 ±
0.02
0.15 ± 
0.02 
Table 2. Associations between measures of placental efficiency and perinatal and postnatal outcomes in term births (37 – 43 weeks). 
Values are odds ratios (and 95% confidence limits) estimating the increase in the odds of the normal outcome per 1 standard deviation 
increase in placental efficiency, i.e., odds ratios are expected to be greater than 1 for all traits. Bold indicates significance at α = 0.05. 
Event Normal   Adverse  Odds ratio for normal outcome 
 outcome # outcome # BW:PW BW0.75:PW Birth weight Residual 
Apgar score at 1 minute 7 or more 21714 3 or less 1330 1.157  
(1.092-1.226) 
1.117  
(1.055-1.182) 
1.160  
(1.096-1.227) 
1.219  
(1.152-1.289) 
Apgar score at 5 minutes 7 or more 26381 3 or less 227 1.254  
(1.093-1.439) 
1.224  
(1.067-1.404) 
1.144  
(1.002-1.306) 
1.272  
(1.115-1.450) 
Apgar score at 10 minutes 7 or more 2720 3 or less 74 1.117  
(0.885-1.410) 
1.095  
(0.867-1.381) 
1.128  
(0.907-1.401) 
1.151  
(0.926-1.430) 
Infant survival from 0 to 
120 days 
Survival 28165 Death 240 1.192  
(1.044-1.360) 
1.093  
(0.960-1.245) 
1.496  
(1.314-1.703) 
1.494  
(1.316-1.695) 
Infant survival from 121-
240 days 
Survival 28165 Death 70 1.182  
(0.926-1.508) 
1.114  
(0.875-1.418) 
1.261  
(0.994-1.599) 
1.309  
(1.036-1.655) 
Infant survival from 241-
365 days 
Survival 28165 Death 22 1.332  
(0.853-2.080) 
1.433  
(0.909-2.257) 
0.733  
(0.486-1.107) 
0.943  
(0.620-1.433) 
 
  
Table 3. Associations between measures of placental efficiency and placental morphology/ pathology in preterm births (24 – 36 
weeks). Values are in standard deviation units and indicate the difference (± standard error) between pregnancies where efficiency is 
expected to be greater (no pathology) and where efficiency is expected to be reduced, i.e., the difference is expected to be positive for 
all traits. Bold indicates significance at α = 0.05. 
Trait Sample size Difference between no pathology and pathology 
No 
pathology 
Pathology BW:PW BW0.75:PW Birth 
weight 
Residual 
Placental examination - Gross 
Type of cord insertion 
     Not membranous vs. marginal or membranous 
4387 210 -0.01 ±
0.07
-0.06 ±
0.07
0.15 ± 
0.07 
0.04 ± 
0.07 
Cut surface infarct size 
     Not applicable or all infarcts less than 3 cm vs. at 
least one infarct measures 3 or more cm 
4482 143 0.16 ±
0.08
0.13 ± 0.08 0.13 ± 
0.08 
0.17 ± 
0.08 
Hemorrhage 
     Absent vs. present 
4386 219 0.45 ± 
0.07 
0.26 ± 0.07 0.69 ± 
0.07 
0.58 ± 
0.07 
Decidual necrosis 
     Not seen grossly or present, not massive vs. present, 
massive 
4317 301 0.18 ± 
0.06 
0.13 ± 0.06 0.20 ± 
0.06 
0.21 ± 
0.06 
Placental examination - Microscopic 
Fetal surface vascular changes 
     None vs. thrombosis and/or necrosis 
4530 47 0.55 ± 
0.15 
0.41 ± 0.15 0.58 ± 
0.15 
0.61 ± 
0.15 
Terminal villi- stromal fibrosis 
     Not seen vs. present 
4459 134 -0.10 ±
0.09
-0.15 ±
0.09
0.08 ± 
0.09 
-0.04 ±
0.09
Terminal villi- pathological edema 
     Not seen vs. present 
4392 201 0.19 ±
0.07
0.12 ± 0.07 0.27 ± 
0.07 
0.28 ±
0.07
Intervillous thrombi and adjacent villous infarction 
     Not seen vs. present 
4225 366 0.02 ±
0.05
0.04 ± 0.05 -0.05 ±
0.05
-0.01 ±
0.05
Apparent maturity of the placenta 
     37 weeks or over vs. 36 weeks or less 
3535 1052 0.31 ±
0.03
0.06 ± 0.04 0.83 ±
0.03
0.56 ±
0.03
Table 4. Associations between measures of placental efficiency and perinatal and postnatal outcomes in preterm births (24 – 36 
weeks). Values are odds ratios (and 95% confidence limits) estimating the increase in the odds of the normal outcome per 1 standard 
deviation increase in placental efficiency, i.e., odds ratios are expected to be greater than 1 for all traits. Bold indicates significance at 
α = 0.05. There were only 6 deaths from 241-365 days of age and so analyses of this age range were not performed. 
Event Normal Adverse Odds ratio for normal outcome 
outcome # outcome # BW:PW BW0.75:PW Birth weight Residual 
Apgar score at 1 minute 7 or more 3100 3 or less 449 1.989  
(1.768-2.238) 
1.404  
(1.258-1.566) 
3.165  
(2.789-3.592) 
2.382  
(2.125-2.671) 
Apgar score at 5 minutes 7 or more 3848 3 or less 191 2.527 
(2.124-3.007) 
1.564  
(1.330-1.840) 
5.222 
(4.256-6.408) 
3.025  
(2.572-3.559) 
Apgar score at 10 minutes 7 or more 617 3 or less 104 2.057  
(1.602-2.642) 
1.324  
(1.052-1.665) 
4.036 
(2.988-5.452) 
2.552  
(1.994-3.265) 
Infant survival from 0 to 
120 days 
Survival 4276 Death 341 2.664 
(2.323-3.055) 
1.676  
(1.477-1.901) 
4.659 
(3.990-5.440) 
3.154  
(2.764-3.600) 
Infant survival from 121-
240 days 
Survival 4276 Death 22 1.244  
(0.794-1.949) 
1.282  
(0.815-2.018) 
0.925  
(0.595-1.439) 
1.158  
(0.752-1.784) 
Figure 1. The relationship between birthweight and placental weight among births between 37 and 43 weeks, inclusive (N = 28497). 
Symbols are shaded according to the BW:PW ratio, and the line is from least-squares regression. 
Figure 2. The relationship between birthweight and placental weight among mature (darker grey) and immature (lighter grey) 
placentas from births between 37 and 43 weeks. Data are presented as 90% confidence ellipses (ELLIPSE statement in proc SGPLOT, 
SAS, Version 9.4) with the overall least-squares regression line. 
Figure 3. The effect of gestational age range on the allometric scaling exponent. The scaling exponent (± standard error), calculated as 
the slope of the regression of the natural logarithm of placental weight on the natural logarithm of birthweight, rises as the range of 
gestational ages narrows (left panel). Sample sizes are shown above the x-axis. The best-fit line from the regression of the natural 
logarithm of placental weight on the natural logarithm of birthweight (right panel), showing the steepest line from the narrowest range 
of gestational ages (40 weeks only, dashed line) compared with the least steep line from widest range of gestational ages (34-42 
weeks, solid line). Births at 40 weeks had among the smallest and largest placentas and babies, therefore the extremes for birth and 
placenta weights were the same for all gestational age ranges. 
Supplemental Figure 1. Distribution of variables for term births (histograms). Curves are normal density estimates (DENSITY 
statement in proc SGPLOT, SAS, Version 9.4). Skewness and kurtosis are expected to be zero for a normal distribution (the kurtosis 
provided is the excess kurtosis). 
Skewness = 0.495 
Kurtosis = 0.649 
Skewness = 0.503 
Kurtosis = 0.508 
Skewness = 0.103 
Kurtosis = 0.063 
Skewness = 0.009 
Kurtosis = 0.232 
Supplemental Figure 2. Distribution of variables for preterm births (histograms). Curves are normal density estimates (DENSITY 
statement in proc SGPLOT, SAS, Version 9.4). Skewness and kurtosis are expected to be zero for a normal distribution (the kurtosis 
provided is the excess kurtosis). 
Skewness = 0.609 
Kurtosis = 2.014 
Skewness = 0.800 
Kurtosis = 2.845 
Skewness = 0.009 
Kurtosis = -0.327 
Skewness = -0.034 
Kurtosis = -0.064 
Supplemental Figure 3. The relationship between birthweight and placental weight among preterm (24 – 36 weeks, N = 4645, left 
panel) and term (37 – 43 weeks, N = 28497, right panel) births. Symbols are shaded according to the BW:PW ratio, and the line is 
from least-squares regression. 
